Table 1.

Baseline characteristics of approved patients enrolled in Italy in the avelumab MCC EAP

Characteristic	n = 102
Age
Median (range), years	70.6 (41.0–92.0)
< 65, n (%)	27 (26.5)
≥ 65, n (%)	75 (73.5)
Sex, n (%)
Female	23 (22.5)
Male	78 (76.5)
Data missing	1 (1.0)
ECOG PS, n (%)
0	52 (51.0)
1	30 (29.4)
2	4 (3.9)
3	1 (1.0)
Data missing	15 (14.7)
Line of therapy, n (%)
1	1 (1.0)
≥ 2	101 (99.0)

EAP expanded access program, ECOG PS Eastern Cooperative Oncology Group performance status, MCC Merkel cell carcinoma